First-in-human study of CMV vaccine HB-101 starts
20 July 2016 | By Victoria White, Digital Content Producer
Hookipa Biotech has announced the start of a first-in-human study to evaluate the safety and immunogenicity of HB-101 against human cytomegalovirus...